Clinical Trials

72 enrolled

Prostatic Neoplasms

NCT02115165 2026-04-06

CABA-GCT

34 enrolled

Nonseminomatous germ cell tumor

NCT02044354 2026-04-01

CABA-DOC

195 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT01616875 2026-03-06

Bristol Bladder Trial

28 enrolled 21 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT05701007 2026-01-29

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Completed

1,083 enrolled 29 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT03556904 2026-01-15

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

14 enrolled 16 charts

Prostatic Neoplasms

NCT02985957 2025-12-22

CheckMate 650

351 enrolled 43 charts

Prostatic Neoplasms

NCT01420250 2025-05-15

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

20 enrolled

Prostatic Neoplasms

NCT01437488 2025-05-04

Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy

14 enrolled 12 charts

Carcinoma, Transitional Cell

NCT02218606 2024-12-10

Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer

81 enrolled 11 charts

Prostatic Neoplasms

NCT02903160 2024-02-07

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

40 enrolled 18 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT02543255 2024-01-31

ACDC-RP

76 enrolled

Prostatic Neoplasms

NCT04495179 2023-08-09

AARDVARC

30 enrolled 22 charts

Prostatic Neoplasms

NCT03114254 2022-11-18

JAVA-P

17 enrolled

Neoplasm Metastasis, Penile Neoplasms, Recurrence

NCT05471427 2022-07-22

ANCHISES

Completed

118 enrolled

Prostatic Neoplasms

NCT03392428 2022-06-13

TheraP

201 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT02485691 2022-05-27

CARD

Phase 4 Completed

255 enrolled 21 charts

Prostate Cancer Metastatic

NCT02961257 2022-05-12

CABASTY

196 enrolled

Prostate Cancer Metastatic

NCT03295565 2022-04-15

OSTRICh

Phase 2/3 Completed

100 enrolled

Neoplasm Metastasis

NCT03101046 2022-02-10

TACTIK

40 enrolled

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT01913652 2021-09-14

Ph II Cabazitaxel DD Liposarcoma

42 enrolled

Sarcoma

Liposarcoma

NCT01505868 2021-07-30

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Completed

170 enrolled 22 charts

Lymphadenopathy, Prostatic Neoplasms

NCT01620242 2021-03-02

ORL03

31 enrolled

Head & Neck

Head and Neck Neoplasms, Recurrence

NCT03419442 2020-10-22

Multi-academic Center Study of Xofigo Patients

Completed

150 enrolled

Prostatic Neoplasms

NCT02560337 2020-10-08

CaTo-ROC

26 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT02512458 2020-02-10

CABA-BONE

60 enrolled

Bone Metastatic Prostate Cancer

NCT01308567 2019-06-05

FIRSTANA

1,168 enrolled 17 charts

Prostatic Neoplasms

NCT01668459 2018-12-04

CabB1

Phase 2/3 Completed

20 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms

NCT01956149 2018-04-18

Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer

65 enrolled

Gastrointestinal

Stomach Neoplasms

NCT01757171 2018-04-03

Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma

85 enrolled 11 charts

Gastrointestinal

Stomach Neoplasms

NCT01718353 2017-11-20

TAXYNERGY

63 enrolled 13 charts

Prostate Cancer Metastatic

NCT01866449 2017-10-26

Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme

24 enrolled

CNS

Glioblastoma

NCT01693549 2017-08-01

Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes

84 enrolled

Breast

Breast Neoplasms

NCT01594918 2017-07-21

Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer

25 enrolled

Neoplasm Metastasis

NCT01518283 2017-07-02

Study of Weekly Cabazitaxel for Advanced Prostate Cancer

74 enrolled

Hormone Refractory Prostate Cancer

NCT01528163 2017-06-14

RACATREX

101 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT01438307 2017-05-24

Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer

28 enrolled 11 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01308580 2017-04-17

PROSELICA

1,200 enrolled 25 charts

Prostatic Neoplasms

NCT02441894 2017-01-24

PEGAZUS

Phase 4 Completed

21 enrolled

Prostatic Neoplasms

NCT01578655 2016-10-12

AFFINITY

630 enrolled

Prostatic Neoplasms

NCT01447225 2016-09-14

Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors

43 enrolled 21 charts

Neoplasms

NCT01751308 2016-08-12

Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors

Phase 1/2 Completed

39 enrolled 18 charts

Other solid neoplasm

Malignant Solid Tumor - Malignant Nervous System Neoplasm

NCT01649635 2016-07-06

PROSPECTA

Phase 4 Completed

45 enrolled

Prostatic Neoplasms

NCT01541007 2015-11-02

ConCab

100 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT01852578 2015-09-28

Cabazitaxel in Relapsed and Metastatic NSCLC

46 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01140607 2015-07-21

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

56 enrolled

Neoplasms

NCT01600339 2015-05-12

A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)

19 enrolled

Carcinoma, Transitional Cell

NCT01500720 2015-04-13

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

179 enrolled 16 charts

Thoracic

Small Cell Lung Carcinoma

NCT01379339 2015-02-11

Cabazitaxel - PF Induction Chemotherapy